PMID: 6968912Sep 1, 1980Paper

Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin

Proceedings of the National Academy of Sciences of the United States of America
K A KrolickE S Vitetta

Abstract

Highly specific antibodies (affinity-purified or hybridoma) directed against cell surface immunoglobulins on normal or neoplastic murine B lymphocytes were covalently coupled to the A chain of the plant toxin ricin. Such conjugates containing antibodies specific for IgM, for either of the two allotypes of IgD, or for the idiotype of the B cell tumor BCL1 rapidly bound in vitro to cells expressing the corresponding surface antigen and inhibited protein synthesis in such cells. The results demonstrate that A chain-coupled anti-idiotype antibody may be useful as a tumor-specific cytotoxic agent.

References

Nov 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D G GillilandT J Moehring
Sep 12, 1979·Biochemical and Biophysical Research Communications·Y MasuhoT Noguchi
Oct 26, 1973·Science·A M Pappenheimer, D M Gill
Jan 1, 1971·Annual Review of Biochemistry·P Cuatrecasas

❮ Previous
Next ❯

Citations

Jan 1, 1983·Springer Seminars in Immunopathology·G T Stevenson, F K Stevenson
Dec 1, 1981·In Vitro·R H Kennett
Feb 28, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·L BonewaldA C Wang
Jan 1, 1981·Journal of Immunological Methods·E Lakow, R S Basch
Feb 11, 1987·Journal of Immunological Methods·P MarderT F Bumol
Jan 1, 1984·Toxicon : Official Journal of the International Society on Toxinology·J C PerezS Y Huang
Jan 1, 1986·Toxicon : Official Journal of the International Society on Toxinology·J Y Lin, S Y Liu
Jan 1, 1991·Toxicon : Official Journal of the International Society on Toxinology·D Avichezer, N Gilboa-Garber
Jan 1, 1981·Pharmacology & Therapeutics·S Olsnes, A Pihl
Jan 1, 1983·Pharmacology & Therapeutics·D C Edwards
Aug 1, 1981·Lancet·G Gregoriadis
Jun 6, 2000·Advanced Drug Delivery Reviews·I Pastan, R J Kreitman
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·C W Vogel, H J Müller-Eberhard
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·P C IsaksonE S Vitetta
Aug 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·M LipinskiL A Herzenberg
Jun 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D EilatR Laskov
Feb 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·I S Trowbridge, F Lopez
Jan 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·T F BumolN O Kaplan
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·C P Leamon, P S Low
Jun 1, 1982·The Journal of Experimental Medicine·K A KrolickE S Vitetta
Aug 1, 1982·The Journal of Experimental Medicine·D J VolkmanD M Neville
Oct 1, 1982·The Journal of Experimental Medicine·D E Yelton, M D Scharff
Mar 1, 1983·The Journal of Experimental Medicine·C C Badger, I D Bernstein
Sep 7, 2007·Cancer Biotherapy & Radiopharmaceuticals·Sotiris Missailidis, Alan Perkins
Oct 10, 2006·The AAPS Journal·Robert J Kreitman
Apr 7, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Robert J Kreitman
Jan 1, 1992·Journal of Neurosurgery·W A Hall, O Fodstad
Feb 8, 2013·Biomarkers in Medicine·Michael S MageeScott A Waldman
Jan 1, 2010·Expert Opinion on Drug Discovery·Rakesh DixitPatricia Clare Ryan
Jan 1, 1997·Critical Reviews in Biotechnology·B Ríhová

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.